Know Labs files S-1, seeks uplisting to NYSE American

Know Labs

Know Labs (OTCQB:KNWN) has filed a Form S-1 registration statement for a proposed offering of three million new shares with an anticipated price of $2 each. Concurrent with, and as a condition to the offering, Know Labs will apply to uplist its shares to the NYSE American Exchange.

If the uplist is approved, Know Labs shares will cease trading on the OTCQB and begin trading on the NYSE American under the proposed new ticker symbol, KNW.

The company intends to use proceeds from the proposed offering for research and development, sales and marketing, general and administrative expenses, capital investments and working capital. Boustead Securities will act as underwriter on a firm commitment basis for the offering.

Know Labs’ technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The Bio-RFID technology can be integrated into a variety of wearable, mobile or bench-top forms.

The technology makes it possible to effectively identify and monitor analytes that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests. The first investigational application of the Bio-RFID technology will be in a product marketed as a non-invasive glucose monitor that will provide the user with real-time information on blood glucose levels.